Literature DB >> 2496988

Oral infections and fever in immunocompromised patients with haematologic malignancies.

O J Bergmann1.   

Abstract

The purpose of the study was to determine the prevalence of acute oral infections and to estimate their role as a possible cause of fever in immunocompromised patients with haematologic malignancies. Seventy-eight febrile episodes in 46 patients were analyzed prospectively and consecutively. An association between a rise in the leukocyte and platelet counts and normalization of the temperature was found. Acute infections were present in 92% of the febrile episodes no infectious cause could be demonstrated in the remaining 8%. Acute oral infections were present during 78% and acute extraoral infections during 73% of the febrile episodes. Acute candidiasis and infected mucosal ulcers were the most prevalent oral infections, occurring in about one-half and one-third of the episodes, respectively. Septicaemia and pneumonia were the most prevalent extraoral infections, each present in about one-fourth of the febrile episodes. Acute oral infections were a probable cause of fever in 14% of the febrile episodes and a possible or a contributing cause of fever in a further 26%. The results suggest that effective treatment or prevention of acute oral infections may reduce the morbidity and perhaps even the mortality in immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2496988     DOI: 10.1007/bf01965262

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  The survival time for different bacteria in various transport media.

Authors:  B Gästrin; L O Kallings; A Marcetic
Journal:  Acta Pathol Microbiol Scand       Date:  1968

2.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

3.  Quantitative analysis of the oral complications of antileukemia chemotherapy.

Authors:  S Dreizen; K B McCredie; G P Bodey; M J Keating
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1986-12

4.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

Authors:  S C Schimpff; H Gaya; J Klastersky; M H Tattersall; S H Zinner
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

5.  Prophylaxis of oropharyngeal candidiasis with clotrimazole.

Authors:  E Yeo; T Alvarado; V Fainstein; G P Bodey
Journal:  J Clin Oncol       Date:  1985-12       Impact factor: 44.544

6.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

7.  Oral infections and septicemia in immunocompromised patients with hematologic malignancies.

Authors:  O J Bergmann
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  Rapid identification of Enterobacteriaceae. II. Use of a beta-glucuronidase detecting agar medium (PGUA agar) for the identification of E. coli in primary cultures of urine samples.

Authors:  M Kilian; P Bülow
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-10

9.  Increased morbidity associated with oral infection in patients with acute nonlymphocytic leukemia.

Authors:  D E Peterson; C D Overholser
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1981-04

10.  Gingivitis in military personnel with special reference to ulceromembranous gingivitis.

Authors:  J J PINDBORG
Journal:  Odontol Tidskr       Date:  1951
View more
  10 in total

1.  Early infections after autologous transplantation for haematological malignancies.

Authors:  I Schiødt; O J Bergmann; H E Johnsen; N E Hansen
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

2.  Oral health status in adult patients with newly diagnosed acute leukemia.

Authors:  Rilana Busjan; Justin Hasenkamp; Gerhard Schmalz; Rainer Haak; Lorenz Trümper; Dirk Ziebolz
Journal:  Clin Oral Investig       Date:  2017-05-23       Impact factor: 3.573

3.  Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.

Authors:  T Tanida; F Rao; T Hamada; E Ueta; T Osaki
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy.

Authors:  M Umazume; E Ueta; T Osaki
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies.

Authors:  O J Bergmann; S C Mogensen; J Ellegaard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

6.  Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study.

Authors:  Judith E Raber-Durlacher; Alexa M G A Laheij; Joel B Epstein; Matthew Epstein; Gerard M Geerligs; Gordon N Wolffe; Nicole M A Blijlevens; J Peter Donnelly
Journal:  Support Care Cancer       Date:  2013-01-04       Impact factor: 3.603

7.  Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial.

Authors:  O J Bergmann; S Ellermann-Eriksen; S C Mogensen; J Ellegaard
Journal:  BMJ       Date:  1995-05-06

8.  Association between the point-rating system used for oral health and the prevalence of Gram-negative bacilli in hematological inpatients: A retrospective cohort study.

Authors:  Kunio Yoshizawa; Akinori Moroi; Ran Iguchi; Hiroshi Yokomichi; Shinji Ogihara; Kazuaki Watanabe; Kei Nakajima; Keita Kirito; Koichiro Ueki
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.889

Review 9.  Does the Microbiome Affect the Outcome of Renal Transplantation?

Authors:  Paul M Campbell; Gavin J Humphreys; Angela M Summers; Joanne E Konkel; Christopher G Knight; Titus Augustine; Andrew J McBain
Journal:  Front Cell Infect Microbiol       Date:  2020-12-23       Impact factor: 5.293

Review 10.  Dental Evaluation Prior to Cancer Therapy.

Authors:  Chee Weng Yong; Andrew Robinson; Catherine Hong
Journal:  Front Oral Health       Date:  2022-04-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.